Bausch Health Companies | VRX - Cash And Equivalent

Stock Price
7.84
Daily Change
0.07 0.90%
Monthly
-25.83%
Yearly
-16.33%
Q1 Forecast
7.62

Bausch Health Companies reported $1.31B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Amgen USD 9.13B 316M Dec/2025
ANI Pharmaceuticals USD 262.61M 44.81M Sep/2025
Aurora Cannabis CAD 95.69M 44.47M Sep/2025
Bausch Health Companies USD 1.31B 419M Sep/2025
Biogen USD 3.86B 1.1B Sep/2025
Bristol-Myers Squibb USD 15.73B 3.13B Sep/2025
Canopy Growth CAD 298.06M 171.86M Sep/2025
Corcept Therapeutics USD 125.14M 22.39M Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Drreddys Laboratories INR 18.66B 9.65B Dec/2025
Eli Lilly USD 9.79B 6.42B Sep/2025
Gilead Sciences USD 5.14B 2.78B Jun/2025
Novo Nordisk A/S DKK 18.44B 5.78B Jun/2025
Pacira USD 147.59M 152.89M Sep/2025
Perrigo USD 432.1M 22.1M Sep/2025
Prestige Brands USD 62.37M 56.73M Dec/2025
Supernus Pharmaceuticals USD 151.37M 6.66M Sep/2025
Vertex Pharmaceuticals USD 6.29B 95.8M Sep/2025
Zoetis USD 2.08B 649M Sep/2025